Jade Biosciences, Inc.
JBIO
$15.03
$0.221.49%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/13/2026
-
Tickeron - Stocks
2/13/2026
-
Tickeron - Stocks
2/12/2026
-
Tickeron - Stocks
2/11/2026
-
Globe Newswire
2/11/2026
-
Tickeron - Stocks
2/10/2026
-
Tickeron - Stocks
2/9/2026
-
Ticker Report
2/9/2026
-
MarketBeat
2/6/2026
-
Tickeron - Stocks
2/6/2026
-
Tickeron - Stocks
2/4/2026
-
Ticker Report
2/3/2026
-
MarketBeat
1/27/2026
-
MarketBeat
1/24/2026
-
Tickeron - Technical Analysis
1/23/2026
-
Ticker Report
1/23/2026
-
MarketBeat
1/23/2026
-
Tickeron - Stocks
1/23/2026
-
Tickeron - Stocks
1/23/2026
-
Tickeron - Stocks
1/22/2026
-
Market News Video
1/22/2026
-
Tickeron - Stocks
1/22/2026
-
Tickeron - Stocks
1/19/2026
-
Yahoo! Finance: News
1/18/2026
-
MarketBeat
1/17/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
781 312 3013
Address
Building 23
Suite 105 - 221 Crescent Street
Waltham, MA 02453
Suite 105 - 221 Crescent Street
Waltham, MA 02453
Country
Year Founded
--
Business Description
Sector
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops...
more